New Zealand to consider batch of reclassifications

25 June 2020 - Deborah Wilkes

Premium

Changes to the status of human papillomavirus (HPV) vaccine, pholcodine and cetirizine will be considered at the next meeting of New Zealand's Medicines Classification Committee (MCC).

Click tags below for more information on topics:

Medsafe

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: